TATE & LYLE RECEIVES INNOVATION IN HEALTH TECHNOLOGY PRODUCT AWARD

Tate & Lyle’s Jessie Han, Sales Director, Greater China, accepts the award

Shanghai, China – 25 June 2026 – Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, is delighted to announce that it has received the Innovation in Health Technology Product Award at the Boao Food for Health Science Conference and Expo (FHE) 2026, recognising its leadership in precision prebiotic technologies and evidence-based nutritional research. 

The award celebrates innovations that demonstrate meaningful scientific advancement, strong validation, and the ability to deliver measurable health benefits in real-world food and beverage applications. 

At the event in Boao, Hainan, China, Tate & Lyle showcased its portfolio of functional oligosaccharide dietary fibres and prebiotic solutions. This includes EUOLIGO® FOS, GOSYAN® GOS, PROMITOR® Soluble Fibre and STA-LITE® Polydextrose – forming a comprehensive and scalable fibre portfolio designed to support gut health and enable product innovation across a wide range of food and beverage applications. 

The breadth and value of Tate & Lyle’s comprehensive fibre portfolio is underpinned by an integrated research framework and application expertise, enabling customers to translate scientific insight into commercially viable products. Together, these capabilities support the development of solutions that are grounded in robust science and designed to perform in real-world conditions. 

Commenting on the award, Remington Zhu, President, Asia Pacific at Tate & Lyle, said: “This award recognises our scientific capabilities and our continued focus on advancing prebiotic innovation. Our approach is centred on translating scientific research into practical solutions that support health while meeting the expectations of both customers and consumers. 

“As demand for functional ingredients continues to grow, we remain focused on delivering solutions that are scientifically robust, scalable, and designed to work across a wide range of applications.” 

This recognition reflects Tate & Lyle’s research capabilities and reinforces its role in advancing science-led innovation across the food and health industry. 

More Articles from the Medical Industry

Cold Chain Innovations for Medical Device Manufacturers

Cold chain logistics is often associated with pharmaceuticals, but its role is expanding into medical technology. Devices such as implants, …

Manufacturing the Future of Healthcare Starts Here

Every breakthrough medical device begins long before it reaches a hospital or a patient. It starts with engineers designing smarter …

Smart Health Asia celebrates highly successful premiere in Singapore

More than 3,000 satisfied visitors – A vibrant atmosphere at the inaugural event at the Marina Bay Sands Expo & …

TATE & LYLE RECEIVES INNOVATION IN HEALTH TECHNOLOGY PRODUCT AWARD

Tate & Lyle’s Jessie Han, Sales Director, Greater China, accepts the award Shanghai, China – 25 June 2026 – Tate …
Share via
Copy link